GEN Exclusives

More »

Legal Affairs

More »
Sep 1, 2009 (Vol. 29, No. 15)

Timing Rules for Biological Deposits in Flux

Proposed Provisions May Wind Up Discouraging Many Patent Applicants

  • Rule Changes

    Under the proposed rule change, “any deposit of biological material [must] be made before publication of a patent application, and…all restrictions on access to the deposited material [must] be removed upon publication.”

    One of the rationales for the proposed rule changes proffered by the USPTO is that the changes aim to bring USPTO practice regarding biological deposits in line with the practice of publishing patent applications under the American Inventors Protection Act (AIPA) of 1999. Under the AIPA, patent applications, subject to certain exceptions, are published 18 months from their earliest priority date. In exchange for publication, the applicant has a provisional right to a reasonable royalty from an infringer from the time of publication of the application to the issuance of the patent under 35 U.S.C. § 154(d).

    The USPTO argues that 35 § U.S.C. 122, as amended by the AIPA, stipulates that only those publications that provide an enabling disclosure are entitled to provisional rights. Although noting that several Federal Circuit decisions, including In re Argoudelis and In re Lundak, held that deposits were required prior to, or at the time the patent became public, i.e., the issue date, the USPTO argues that such cases were decided before, and therefore, superseded by, the AIPA.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »